Pirfenidone treatment in idiopathic pulmonary fibrosis: nationwide Danish results
Pirfenidone was approved by the European Medicines Agency and introduced in most European countries in 2011 for treatment of idiopathic pulmonary fibrosis (IPF). To describe the national Danish experiences of pirfenidone treatment for IPF during 30 months with respect to target population, safety, a...
Saved in:
Published in | European clinical respiratory journal Vol. 3; no. 1; p. 32608 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
Taylor & Francis
2016
Co-Action Publishing Taylor & Francis Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!